Recognition and degradation of plant cell wall polysaccharides by two human gut symbionts von Martens, Eric C, Lowe, Elisabeth C, Chiang, Herbert, Pudlo, Nicholas A, Wu, Meng, McNulty, Nathan P, Abbott, D Wade, Henrissat, Bernard, Gilbert, Harry J, Bolam, David N, Gordon, Jeffrey I

Volltext

Effects of diet on resource utilization by a model human gut microbiota containing Bacteroides cellulosilyticus WH2, a symbiont with an extensive glycobiome von McNulty, Nathan P, Wu, Meng, Erickson, Alison R, Pan, Chongle, Erickson, Brian K, Martens, Eric C, Pudlo, Nicholas A, Muegge, Brian D, Henrissat, Bernard, Hettich, Robert L, Gordon, Jeffrey I

Volltext

Guidelines for morpholino use in zebrafish von Stainier, Didier Y R, Raz, Erez, Lawson, Nathan D, Ekker, Stephen C, Burdine, Rebecca D, Eisen, Judith S, Ingham, Philip W, Schulte-Merker, Stefan, Yelon, Deborah, Weinstein, Brant M, Mullins, Mary C, Wilson, Stephen W, Ramakrishnan, Lalita, Amacher, Sharon L, Neuhauss, Stephan C F, Meng, Anming, Mochizuki, Naoki, Panula, Pertti, Moens, Cecilia B

Volltext

Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up von Escudier, B, Porta, C, Schmidinger, M, Algaba, F, Patard, J J, Khoo, V, Eisen, T, Horwich, A

Volltext

Problems and Questions von Tobin, Cyril, Piza, P. A., Moser, Leo, Goldberg, Michael, Qualley, A. O., Horton, R. E., Kellogg, Bruce, Nagara, P. N., Eves, Howard, Talbot, W. R., Starke, E. P., Court, N. A., Thomas, P. D., Cromelin, J. S., Thebault, Victor, Marer, Fred, Mackay, D. L., Epstein, A. L., Byrne, W. E., Fettis, H. E., Struyk, Adrian, Eisen, Nathan

Volltext

Regorafenib for patients with previously untreated metastatic or unresectable renal-cell carcinoma: a single-group phase 2 trial von Eisen, Tim, Prof, Joensuu, Heikki, Prof, Nathan, Paul D, PhD, Harper, Peter G, FRCP, Wojtukiewicz, Marek Z, Prof, Nicholson, Steve, MD, Bahl, Amit, MD, Tomczak, Piotr, PhD, Pyrhonen, Seppo, Prof, Fife, Kate, MD, Bono, Petri, PhD, Boxall, Jane, RN, Wagner, Andrea, MD, Jeffers, Michael, PhD, Lin, Tiffany, PharmD, Quinn, David I, FRACP

Volltext

Establishment and characterization of a highly tumourigenic and cancer stem cell enriched pancreatic cancer cell line as a well defined model system von Fredebohm, Johannes, Boettcher, Michael, Eisen, Christian, Gaida, Matthias M, Heller, Anette, Keleg, Shereen, Tost, Jörg, Greulich-Bode, Karin M, Hotz-Wagenblatt, Agnes, Lathrop, Mark, Giese, Nathalia A, Hoheisel, Jörg D

Volltext

Consensus conference on heart‐kidney transplantation von Kobashigawa, Jon, Dadhania, Darshana M., Farr, Maryjane, Tang, W. H. Wilson, Bhimaraj, Arvind, Czer, Lawrence, Hall, Shelley, Haririan, Abdolreza, Formica, Richard N., Patel, Jignesh, Skorka, Rafael, Fedson, Savitri, Srinivas, Titte, Testani, Jeffrey, Yabu, Julie M., Cheng, Xingxing S., Adler, Eric, Akalin, Enver, Anderson, Allen, Birdwell, Kelly, Cohen, David, Crew, R. John, Eisen, Howard, Feller, Erika, Fischbach, Bernie, Gallon, Lorenzo, Gass, Alan, Gonzalez, Juan, Horn, Evelyn, Inker, Lesley, Johnson, Maryl, Khush, Kiran, Lefkowitz, Heather, Moiz, Abdul, Nathan, Sriram, Nsair, Ali, Peng, Alice, Poggio, Emilio, Radovancevic, Rajko, Ravichandran, Ashwin, Serur, David, Zucker, Mark

Volltext

The complete genome of Teredinibacter turnerae T7901: an intracellular endosymbiont of marine wood-boring bivalves (shipworms) von Yang, Joyce C, Madupu, Ramana, Durkin, A Scott, Ekborg, Nathan A, Pedamallu, Chandra S, Hostetler, Jessica B, Radune, Diana, Toms, Bradley S, Henrissat, Bernard, Coutinho, Pedro M, Schwarz, Sandra, Field, Lauren, Trindade-Silva, Amaro E, Soares, Carlos A G, Elshahawi, Sherif, Hanora, Amro, Schmidt, Eric W, Haygood, Margo G, Posfai, Janos, Benner, Jack, Madinger, Catherine, Nove, John, Anton, Brian, Chaudhary, Kshitiz, Foster, Jeremy, Holman, Alex, Kumar, Sanjay, Lessard, Philip A, Luyten, Yvette A, Slatko, Barton, Wood, Nicole, Wu, Bo, Teplitski, Max, Mougous, Joseph D, Ward, Naomi, Eisen, Jonathan A, Badger, Jonathan H, Distel, Daniel L

Volltext

Temporary treatment cessation compared with continuation of tyrosine kinase inhibitors for adults with renal cancer: the STAR non-inferiority RCT von Collinson, Fiona, Royle, Kara-Louise, Swain, Jayne, Ralph, Christy, Maraveyas, Anthony, Eisen, Tim, Nathan, Paul, Jones, Robert, Meads, David, Min Wah, Tze, Martin, Adam, Bestall, Janine, Kelly-Morland, Christian, Linsley, Christopher, Oughton, Jamie, Chan, Kevin, Theodoulou, Elisavet, Arias-Pinilla, Gustavo, Kwan, Amy, Daverede, Luis, Handforth, Catherine, Trainor, Sebastian, Salawu, Abdulazeez, McCabe, Christopher, Goh, Vicky, Buckley, David, Hewison, Jenny, Gregory, Walter, Selby, Peter, Brown, Julia, Brown, Janet

Volltext

Adjuvant Sorafenib for Renal Cell Carcinoma at Intermediate or High Risk of Relapse: Results From the SORCE Randomized Phase III Intergroup Trial von Eisen, Tim, Frangou, Eleni, Oza, Bhavna, Ritchie, Alastair W. S., Smith, Benjamin, Kaplan, Rick, Davis, Ian D., Stockler, Martin R., Albiges, Laurence, Escudier, Bernard, Larkin, James, Bex, Axel, Joniau, Steven, Hancock, Barry, Hermann, Gregers G., Bellmunt, Joaquim, Hodgkinson, Elizabeth, Stewart, Grant D., Barber, Jim, Brown, Janet, McMenemin, Rhona, Nathan, Paul, Pickering, Lisa M., Parmar, Mahesh K. B., Meade, Angela

Volltext

Guidelines for the definition of time-to-event end points in renal cell cancer clinical trials: results of the DATECAN project von Kramar, A., Negrier, S., Sylvester, R., Joniau, S., Mulders, P., Powles, T., Bex, A., Bonnetain, F., Bossi, A., Bracarda, S., Bukowski, R., Catto, J., Choueiri, T.K., Crabb, S., Eisen, T., El Demery, M., Fitzpatrick, J., Flamand, V., Goebell, P.J., Gravis, G., Houédé, N., Jacqmin, D., Kaplan, R., Malavaud, B., Massard, C., Melichar, B., Mourey, L., Nathan, P., Pasquier, D., Porta, C., Pouessel, D., Quinn, D., Ravaud, A., Rolland, F., Schmidinger, M., Tombal, B., Tosi, D., Vauleon, E., Volpe, A., Wolter, P., Escudier, B., Filleron, T., Kramar, Andrew, Sylvester, Richard, Filleron, Thomas, Negrier, Sylvie, Joniau, Steven, Mulders, Peter, Powles, Thomas, Escudier, Bernard, Bex, Axel, Bonnetain, Franck, Bossi, Alberto, Braccarda, Sergio, Bukowski, Ronald, Catto, James, Choueiri, Toni, Crabb, Simon, Eisen, Tim, El Demery, Mounira, Fitzpatrick, John, Flamand, Vincent, Goebell, Peter J., Gravis, Gwendael, Houédé, Nadine, Jacqmin, Didier, Kaplan, Richard, Malavaud, Bernard, Massard, Christophe, Melichar, Bohuslav, Mourey, Loïc, Nathan, Paul, Pasquier, David, Porta, Camillo, Pouessel, Damien, Quinn, David, Ravaud, Alain, Rolland, Frédéric, Schmidinger, Manuela, Tombal, Bertrand, Tosi, Diego, Vauleon, Elodie, Volpe, Alessandro, Wolter, Pascal

Volltext

RAMPART: A phase III multi-arm multi-stage trial of adjuvant checkpoint inhibitors in patients with resected primary renal cell carcinoma (RCC) at high or intermediate risk of rela... von Oza, Bhavna, Frangou, Eleni, Smith, Ben, Bryant, Hanna, Kaplan, Rick, Choodari-Oskooei, Babak, Powles, Tom, Stewart, Grant D., Albiges, Laurence, Bex, Axel, Choueiri, Toni K., Davis, Ian D., Eisen, Tim, Fielding, Alison, Harrison, David, McWhirter, Anita, Mulhere, Salena, Nathan, Paul, Rini, Brian, Ritchie, Alastair, Scovell, Sarah, Shakeshaft, Clare, Stockler, Martin R., Thorogood, Nat, Parmar, Mahesh K.B., Larkin, James, Meade, Angela

Volltext

Sorafenib for Older Patients With Renal Cell Carcinoma: Subset Analysis From a Randomized Trial von Eisen, Tim, Oudard, Stéphane, Szczylik, Cezary, Gravis, Gwenaelle, Heinzer, Hans, Middleton, Richard, Cihon, Frank, Anderson, Sibyl, Shah, Sonalee, Bukowski, Ronald, Escudier, Bernard

Volltext

Adapting the design of the ongoing RAMPART trial in response to external evidence: An example for trials which take many years to run and report von Meade, Angela, Frangou, Elena, Choodari-Oskooei, Babak, Larkin, James, Powles, Tom, Stewart, Grant D., Albiges, Laurence, Bex, Axel, Choueiri, Toni K., Davis, Ian D., Eisen, Tim, Fielding, Alison, Gedye, Craig, Harrison, David J., Kaplan, Rick, Mulhere, Salena, Nathan, Paul, Patel, Grisma, Patel, Jay, Plant, Hannah, Ritchie, Alastair, Rush, Hannah, Shakeshaft, Clare, Stockler, Martin R., Suarez, Cristina, Thompson, Jemima, Thorogood, Nat, Venugopal, Balaji, Parmar, Mahesh K.B.

Volltext

Multi-disease data management system platform for vector-borne diseases von Eisen, Lars, Coleman, Marlize, Lozano-Fuentes, Saul, McEachen, Nathan, Orlans, Miguel, Coleman, Michael

Volltext

Sorafenib and dacarbazine as first-line therapy for advanced melanoma: phase I and open-label phase II studies von Eisen, T, Marais, R, Affolter, A, Lorigan, P, Robert, C, Corrie, P, Ottensmeier, C, Chevreau, C, Chao, D, Nathan, P D, Jouary, T, Harries, M, Negrier, S, Montegriffo, E, Ahmad, T, Gibbens, I, James, M G, Strauss, U P, Prendergast, S, Gore, M E

Volltext

The biological treatment of renal-cell carcinoma and melanoma von Nathan, Paul D, Eisen, Tim G

Volltext

Adjuvant Sorafenib for Renal Cell Carcinoma at Intermediate or High Risk of Relapse: Results From the SORCE Randomized Phase III Intergroup Trial von Eisen, Tim, Frangou, Eleni, Oza, Bhavna, Ritchie, Alastair W.S, Smith, Benjamin, Kaplan, Rick, Davis, Ian D, Stockler, Martin R, Albiges, Laurence, Escudier, Bernard, Larkin, James, Bex, Axel, Joniau, Steven, Hancock, Barry, Hermann, Gregers G, Bellmunt, Joaquim, Hodgkinson, Elizabeth, Stewart, Grant D, Barber, Jim, Brown, Janet, McMenemin, Rhona, Nathan, Paul, Pickering, Lisa M, Parmar, Mahesh K.B, Meade, Angela

Volltext

Prospective comparison of RECIST and alternative response assessment criteria in the evaluation of metastatic renal cell cancer patients from phase II of the multi-centre randomise... von Kelly-Morland, C., Zhong, J., Goh, V., Wah, T., Ralph, C., Thistlethwaite, F., Patel, P., Nathan, P., Eisen, T., Gregory, W., McParland, L., Cool, H., Royle, K-L., Best, E., Whincup, L., Collinson, F., Brown, J.

Volltext